Maxcyte (MXCT) EBITDA Margin (2020 - 2026)
Maxcyte (MXCT) posted EBITDA Margin of -127.27% for Q2 2026, up 27.04 percentage points from -154.31% a year earlier but down 74.03 percentage points from the prior quarter.
Powered by 
Analysis
Maxcyte (MXCT) EBITDA Margin (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Maxcyte was -121.17%, up 16.32 percentage points year-over-year; for FY2025, it came in at -144.00%, down 22.63 percentage points from FY2024.
- Annual EBITDA Margin has declined for five consecutive years, with a five-year change of -105.75 percentage points (FY2020 to FY2025).
- In prior years, Maxcyte's EBITDA Margin was -121.37% in FY2024 (-14.49 pp), -106.88% in FY2023 (-51.16 pp), -55.72% in FY2022 (-6.26 pp) and -49.46% in FY2021 (-11.21 pp).
- Quarterly EBITDA Margin has run from a low of -191.49% in Q3 2025 to a high of -20.48% in Q3 2021 over five years.
- On a year-over-year basis, EBITDA Margin increased in three of the last eight quarters, with an average year-over-year change of -12.85 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q1 2022, with a gain of 61.57 percentage points; the weakest was Q1 2023, with a drop of 110.76 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -53.24% (Q1 2026), -139.10% (Q4 2025) and -191.49% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.84 Bn | 229.99 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 174.73 Bn | 145.82 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 159.85 Bn | 143.67 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 146.79 Bn | 126.35 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 114.54 Bn | 80.41 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 105.67 Bn | 91.79 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 63.93 Bn | 58.94 Bn | 3.85 Bn | 28.17% |
| 8 | Becton Dickinson | 50.12 Bn | 47.27 Bn | 2.32 Bn | 24.62% |
| 9 | Edwards Lifesciences | 50.06 Bn | 34.17 Bn | 1.35 Bn | 31.93% |
| 10 | Maxcyte | 123.12 Mn | 123.12 Mn | 5.60 Mn | -127.27% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -127.27% |
| Mar 31, 2026 | -53.24% |
| Dec 31, 2025 | -139.10% |
| Sep 30, 2025 | -191.49% |
| Jun 30, 2025 | -154.31% |
| Mar 31, 2025 | -107.79% |
| Dec 31, 2024 | -136.25% |
| Sep 30, 2024 | -159.08% |
| Jun 30, 2024 | -104.39% |
| Mar 31, 2024 | -98.43% |
| Dec 31, 2023 | -44.65% |
| Sep 30, 2023 | -160.81% |
| Jun 30, 2023 | -133.22% |
| Mar 31, 2023 | -142.44% |
| Dec 31, 2022 | -46.94% |
| Sep 30, 2022 | -65.48% |
| Jun 30, 2022 | -85.26% |
| Mar 31, 2022 | -31.69% |
| Dec 31, 2021 | -44.71% |
| Sep 30, 2021 | -20.48% |
API Access
Maxcyte EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MXCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "MXCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MXCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();